Authors




Paul Feuerstadt, MD

Latest:

Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).


Anna Zhou, PharmD, BCIDP

Latest:

COVID-19 Impact on Antimicrobial Stewardship: Consequences and Silver Linings

This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.


Lana Pine

Latest:

Combination Hepatitis C Therapy Efficacious in Those With Previously Untreated Acute Infection

Treatment with glecaprevir/pibrentasvir (G/P) demonstrated a virologic response at post-treatment week 12, which was superior to the prior efficacy threshold.


Christopher M. Bland, PHARMD, FCCP, FIDSA, BCPS

Latest:

Starting an Inpatient Penicillin Skin Testing Service in 2023

Patients with a penicillin allergy can be safely delabeled using minimal resources, opening up treatment options.


Mohamed Hisham, PharmD, BCCCP, BCIDP

Latest:

All About the JUICE: Justifying Use of Non-Carbapenems for Infected NeCrotizing PancrEatitis

Management of this condition has been associated with antibiotic misuse. In the latest Bench to Bedside column, clinicians offer insights on therapy indications and what the latest literature reports on the condition.


Alice Hemenway, PharmD, BCPS, BCIDP, MPH

Latest:

The Role of Rifampin in Bone and Joint Infections

In the latest column from the Society of Infectious Diseases Pharmacists (SIDP), here is a discussion on the use of rifampin as an adjunctive antibiotic treatment for patients with diabetic foot osteomyelitis.


Lois Levine, MA

Latest:

What You Need to Know About 3 Rare Infectious Eye Diseases

Eric D. Donnenfeld, MD, discusses 3 uncommon yet highly infectious eye diseases, emphasizing the importance of timely treatment and preventative measures.


Jelena Lewis, PharmD, BCACP

Latest:

What’s New With Non–COVID-19 Vaccines

Although COVID-19 vaccination remains the primary focus for health care, other paramount vaccines need to be recognized. Here is a review.


Marian Freedman

Latest:

Fluoroquinolone Safe for Treating Severe Refractory M Pneumoniae Pneumonia

Investigators asked the children’s parents about the history of musculoskeletal-related disease, observed the children’s gait, and performed physical examinations.


Matthew J. Grant, MD

Latest:

Barriers to Health Care Transition in Adolescents and Young Adults With Early Acquired HIV Infection

Unique challenges can affect the success of the shift from pediatric to adult care settings.


Tavell Kindall, PhD, DNP, APRN, FNP

Latest:

Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.


Tina Tan, MD

Latest:

Practice Pearls for Treatment of Respiratory Infections

Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.


Lakecia Pitts, MD, MBA

Latest:

Resources Available for Patients with HIV Drug Resistance

The panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.


Claudine El-Beyrouty, PharmD, BCPS

Latest:

Examining RSV Vaccines for Seniors

Two RSV vaccines for seniors were FDA approved this year and here is an overview of the vaccines and the study data.


Meghan N. Jeffres, PharmD, BCIDP

Latest:

Antimicrobial Stewardship: More Is Better

A robust stewardship program requires a comprehensive investment in technology and staff.



Samuel L. Aitken, PharmD, MPH; and Cornelius J. Clancy, MD

Latest:

IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

Since late 2004, 7 novel antibiotics with activity against ESBL-E, CRE, and/or DTR P aeruginosa have been approved.


Itay Klaz, MD, MHCI

Latest:

5 Strategies for Improving Sepsis Care Management

Hospitalists can be better equipped to identify patients most in need of intervention and standardize sepsis management efforts.



Kimberly Humphrey, MBBS, MPH

Latest:

Climate Change Effects on Vector-Borne Disease: The Case of Lyme

With evolving weather patterns, the natural habitat of ticks is expanding, and more people are becoming susceptible to them.


Han Wei, BMED, PhD

Latest:

Backpack Science: Enabling Realtime Work in the Field for Genomic Testing of Infectious Diseases

Gathering data in the field, especially when it relates to infectious disease may have potentially profound implications for research because it enables scientists to generate valuable data quickly and efficiently without having to be in a laboratory setting.


Mandee Noval, PHARMD, BCIDP

Latest:

Stronger Than Yesterday: Decreased Hospital Readmissions After Strengthening of an OPAT Program

Although close clinician monitoring is warranted to avoid complications for this this type of treatment, it can be beneficial to patients and help reduce care costs.


Lina Meng, PharmD, BCIDP, BCCCP

Latest:

Vancomycin AUC Implementation in Resource-Limited Settings and its Associated Difficulties

The latest article from SIDP illustrates the challenges of area under the curve (AUC) implementation and offers insights for strategies and resources to overcome them.


Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc

Latest:

From Pathogen to Infectious Disease Diagnosis

Here is our inaugural podcast with our host, Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, who interviews guests on connecting lab professionals to clinicians and the intricacies of assays, the next generation of diagnostics, and the nuances of interpreting test results.


Joy Uzoma, PharmD, BCIDP

Latest:

Challenging the Status Quo: Oral Transitional Therapy for Infective Endocarditis

New evidence suggests that oral transitional therapy may be a promising option for the treatment of infective endocarditis (IE). A retrospective cohort study reveals comparable clinical outcomes between oral and intravenous antibiotic regimens.


Sylvia Ou, PharmD

Latest:

A Case of Candida Albicans Ventriculitis Secondary to E Coli Ventriculoperitoneal Shunt Infection

Rare cases of health care–associated meningitis and ventriculitis in adults caused by Candida species are associated with recent bacterial meningitis and broad-spectrum antibiotic use.


Conan MacDougall, PharmD, MAS, BCPS, BCIDP

Latest:

Children, COVID-19, and Another Crazy Respiratory Viral Season

Kevin J. Downes, MD, and Contagion® Section Editor Conan MacDougall, PharmD, MAS, BCPS, BCIDP, discuss these important topics as another season approaches.


Leslie McGorman, MPPA

Latest:

Political and Social Barriers to Ending the HIV Epidemic

Learning about these barriers is the first step to overcoming them.

© 2024 MJH Life Sciences

All rights reserved.